Search for other papers by W J Bom in
Google Scholar
PubMed
Search for other papers by F B M Joosten in
Google Scholar
PubMed
Search for other papers by M M G J van Borren in
Google Scholar
PubMed
Search for other papers by E P Bom in
Google Scholar
PubMed
Search for other papers by R R J P van Eekeren in
Google Scholar
PubMed
Search for other papers by H de Boer in
Google Scholar
PubMed
bars indicate that the interventions took place in the second half of the first year: white-striped red and blue bars represent interventions after the first year. The patient with a solitary B-cell lymphoma diagnosed in the second year after RFA is
Search for other papers by Carina Hasenoehrl in
Google Scholar
PubMed
Search for other papers by Gert Schwach in
Google Scholar
PubMed
SFL Chicken CAM Lab, Institute of Pathophysiology and Immunology, Medical University of Graz, Graz, Austria
Search for other papers by Nassim Ghaffari-Tabrizi-Wizsy in
Google Scholar
PubMed
Search for other papers by Robert Fuchs in
Google Scholar
PubMed
Search for other papers by Nadine Kretschmer in
Google Scholar
PubMed
Search for other papers by Rudolf Bauer in
Google Scholar
PubMed
Search for other papers by Roswitha Pfragner in
Google Scholar
PubMed
.1–2 µg/mL (EX) for 72 h. A dose-dependent reduction of cell proliferation was seen for all examined compounds ( Fig. 1B ). Table 1 shows IC 50 values as mean ± s.d. of at least three independent experiments. To allow for comparison of potency of the
Search for other papers by M L Gild in
Google Scholar
PubMed
Search for other papers by M Bullock in
Google Scholar
PubMed
Search for other papers by C K Pon in
Google Scholar
PubMed
Cancer Genetics Laboratory, Department of Endocrinology, Kolling Institute of Medical Research, Sydney, New South Wales, Australia
Search for other papers by B G Robinson in
Google Scholar
PubMed
Cancer Genetics Laboratory, Department of Endocrinology, Kolling Institute of Medical Research, Sydney, New South Wales, Australia
Search for other papers by R J Clifton-Bligh in
Google Scholar
PubMed
% of cases of MEN2B syndrome). TPC-1 cells harbor the RET-PTC1 rearrangement which consists of a fusion gene between RET and CCDC6 . All three cell lines have been genetically fingerprinted by either SNP-CGH or polymorphic short tandem repeat (STR
Search for other papers by Monia Cito in
Google Scholar
PubMed
Search for other papers by Silvia Pellegrini in
Google Scholar
PubMed
Vita-Salute San Raffaele University, Milan, Italy
Search for other papers by Lorenzo Piemonti in
Google Scholar
PubMed
Search for other papers by Valeria Sordi in
Google Scholar
PubMed
Gürtler M Pagliuca FW Melton DA . Generation of stem cell-derived b-cells from patients with type 1 diabetes. Nature Communications 2016 7 11463 . ( https://doi.org/10.1038/ncomms11463 ) 10.1038/ncomms11463 13
Centro de Investigaciones en Bioquímica Clínica e Inmunología (CIBICI-CONICET), Haya de la Torre y Medina Allende, Ciudad Universitaria, Córdoba (X5000HUA), Argentina
Search for other papers by Rocío del Carmen Bravo-Miana in
Google Scholar
PubMed
Centro de Investigaciones en Bioquímica Clínica e Inmunología (CIBICI-CONICET), Haya de la Torre y Medina Allende, Ciudad Universitaria, Córdoba (X5000HUA), Argentina
Search for other papers by Ana Belén Della Vedova in
Google Scholar
PubMed
Instituto de Investigaciones en Ciencias de la Salud (INICSA-CONICET), Av. Enrique Barros y Enfermera Gordillo, Ciudad Universitaria, Córdoba, Argentina
Search for other papers by Ana Lucía De Paul in
Google Scholar
PubMed
Centro de Investigaciones en Bioquímica Clínica e Inmunología (CIBICI-CONICET), Haya de la Torre y Medina Allende, Ciudad Universitaria, Córdoba (X5000HUA), Argentina
Search for other papers by María Mónica Remedi in
Google Scholar
PubMed
Centro de Investigaciones en Bioquímica Clínica e Inmunología (CIBICI-CONICET), Haya de la Torre y Medina Allende, Ciudad Universitaria, Córdoba (X5000HUA), Argentina
Search for other papers by María Laura Guantay in
Google Scholar
PubMed
Centro de Investigaciones en Bioquímica Clínica e Inmunología (CIBICI-CONICET), Haya de la Torre y Medina Allende, Ciudad Universitaria, Córdoba (X5000HUA), Argentina
Search for other papers by Mónica Beatriz Gilardoni in
Google Scholar
PubMed
Centro de Investigaciones en Bioquímica Clínica e Inmunología (CIBICI-CONICET), Haya de la Torre y Medina Allende, Ciudad Universitaria, Córdoba (X5000HUA), Argentina
Search for other papers by Claudia Gabriela Pellizas in
Google Scholar
PubMed
Centro de Investigaciones en Bioquímica Clínica e Inmunología (CIBICI-CONICET), Haya de la Torre y Medina Allende, Ciudad Universitaria, Córdoba (X5000HUA), Argentina
Search for other papers by Ana Carolina Donadio in
Google Scholar
PubMed
condition (Medium) and as b for 8505c cells treated with Fb-8505c CMs vs basal condition. CMs, Conditioned media. Soluble factors of Fb and Fb-8505c CMs promote 2D-migration of 8505c tumor cells To further investigate the effect of
Search for other papers by Irasema Mendieta in
Google Scholar
PubMed
Search for other papers by Rosa Elvira Nuñez-Anita in
Google Scholar
PubMed
Search for other papers by Gilberto Pérez-Sánchez in
Google Scholar
PubMed
Search for other papers by Lenin Pavón in
Google Scholar
PubMed
Search for other papers by Alfredo Rodríguez-Cruz in
Google Scholar
PubMed
Search for other papers by Guadalupe García-Alcocer in
Google Scholar
PubMed
Search for other papers by Laura Cristina Berumen in
Google Scholar
PubMed
overexpression of CgA ( Fig. 3B ). Figure 3 Effect of cAMP-elevating agents on neuroendocrine biomarker expression of A549 cell line. A549 cells were exposed to IBMX (0.5 mM), FSK (0.5 mM) or I + F for 120 h. (A) The level of neuroendocrine marker CgA was
Search for other papers by Juan Carlos Juárez-Cruz in
Google Scholar
PubMed
Search for other papers by Miriam Daniela Zuñiga-Eulogio in
Google Scholar
PubMed
Search for other papers by Monserrat Olea-Flores in
Google Scholar
PubMed
Search for other papers by Eduardo Castañeda-Saucedo in
Google Scholar
PubMed
Search for other papers by Miguel Ángel Mendoza-Catalán in
Google Scholar
PubMed
Search for other papers by Carlos Ortuño-Pineda in
Google Scholar
PubMed
Search for other papers by Ma Elena Moreno-Godínez in
Google Scholar
PubMed
Search for other papers by Sócrates Villegas-Comonfort in
Google Scholar
PubMed
Search for other papers by Teresita Padilla-Benavides in
Google Scholar
PubMed
Search for other papers by Napoleón Navarro-Tito in
Google Scholar
PubMed
/mL of leptin present a significant increase in FAK phosphorylation on Y397, after 10 min of treatment and peaked after 15 min compared to the non-treated control cells ( Fig. 1A and B ). Leptin also activates FAK in MCF7 cells, as Y397 phosphorylation
Search for other papers by Wenrui Wang in
Google Scholar
PubMed
Search for other papers by Chuan Zhang in
Google Scholar
PubMed
. Figure 2 Mechanisms of β-cell dedifferentiation. (A) Reduced expression of raptor-induced suppression of the mTORC1 signaling pathway increased the expressions of β-cell-specific disallowed genes (e.g. Hk1 , Dlk1 , Pdgfra , Oat , and Mylk ). (B
Search for other papers by Jiwen Yang in
Google Scholar
PubMed
Search for other papers by Yayin Huang in
Google Scholar
PubMed
Search for other papers by Bohan Dong in
Google Scholar
PubMed
Search for other papers by Yunhai Dai in
Google Scholar
PubMed
and BHT-101 cells ( Fig. 2B ). We selected si-DLEU2 #2 and si-DLEU2 #3 to conduct loss-of-function experiments. As mentioned in Fig. 2C and D , DLEU2 depletion significantly suppressed cell proliferation in thyroid cancer cells. Besides, DLEU2
Université Côte d'Azur, INSERM, C3M, Team Cellular and Molecular Physiopathology of Obesity and Diabetes, Nice, France
Search for other papers by Hichem Bouguerra in
Google Scholar
PubMed
Search for other papers by Gorrab Amal in
Google Scholar
PubMed
Search for other papers by Stephan Clavel in
Google Scholar
PubMed
Search for other papers by Hamouda Boussen in
Google Scholar
PubMed
Search for other papers by Jean-François Louet in
Google Scholar
PubMed
Search for other papers by Asma Gati in
Google Scholar
PubMed
was found on Fas, MICA/B or MHC-I expression ( Fig. 1B ). Figure 1 Leptin decreases the susceptibility of MCF-7 to NK92 lysis. (A) The impact of leptin on MCF-7 tumor cells to NK92-mediated lysis was studied. MCF-7 were incubated with two